Literature DB >> 26238713

Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection.

Michael J Noto1, Kelli L Boyd2, William J Burns3, Matthew G Varga4, Richard M Peek4, Eric P Skaar5.   

Abstract

Acinetobacter baumannii is a common nosocomial pathogen capable of causing severe diseases associated with significant morbidity and mortality in impaired hosts. Pattern recognition receptors, such as the Toll-like receptors (TLRs), play a key role in pathogen detection and function to alert the immune system to infection. Here, we examine the role for TLR9 signaling in response to A. baumannii infection. In a murine model of A. baumannii pneumonia, TLR9(-/-) mice exhibit significantly increased bacterial burdens in the lungs, increased extrapulmonary bacterial dissemination, and more severe lung pathology compared with those in wild-type mice. Following systemic A. baumannii infection, TLR9(-/-) mice have significantly increased bacterial burdens in the lungs, as well as decreased proinflammatory cytokine and chemokine production. These results demonstrate that TLR9-mediated pathogen detection is important for host defense against the opportunistic pathogen Acinetobacter baumannii.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238713      PMCID: PMC4567622          DOI: 10.1128/IAI.00410-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.

Authors:  Zubair A Qureshi; Lauren E Hittle; Jessica A O'Hara; Jesabel I Rivera; Alveena Syed; Ryan K Shields; Anthony W Pasculle; Robert K Ernst; Yohei Doi
Journal:  Clin Infect Dis       Date:  2015-01-28       Impact factor: 9.079

2.  Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia.

Authors:  Sylvia Knapp; Catharina W Wieland; Sandrine Florquin; Ralph Pantophlet; Lenie Dijkshoorn; Ntambua Tshimbalanga; Shizuo Akira; Tom van der Poll
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

3.  genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.

Authors:  M Indriati Hood; Kyle W Becker; Christelle M Roux; Paul M Dunman; Eric P Skaar
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

4.  Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.

Authors:  Sun Bean Kim; Yoo Hong Min; June-Won Cheong; Jin Seok Kim; Soo Jeong Kim; Nam Su Ku; Su Jin Jeong; Sang Hoon Han; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Scand J Infect Dis       Date:  2013-12-11

5.  Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection.

Authors:  M Indriati Hood; Roman Uzhachenko; Kelli Boyd; Eric P Skaar; Alla V Ivanova
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

6.  Expression of Toll-like receptor 9 in mouse and human lungs.

Authors:  David Schneberger; Sarah Caldwell; Rani Kanthan; Baljit Singh
Journal:  J Anat       Date:  2013-03-22       Impact factor: 2.610

7.  The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection.

Authors:  Pradeep Bist; Neha Dikshit; Tse Hsien Koh; Alessandra Mortellaro; Thuan Tong Tan; Bindu Sukumaran
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

8.  Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9.

Authors:  Dane Parker; Alice Prince
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

9.  Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration.

Authors:  M Indriati Hood; Brittany L Mortensen; Jessica L Moore; Yaofang Zhang; Thomas E Kehl-Fie; Norie Sugitani; Walter J Chazin; Richard M Caprioli; Eric P Skaar
Journal:  PLoS Pathog       Date:  2012-12-06       Impact factor: 6.823

10.  Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection.

Authors:  Hongyu Qiu; Rhonda KuoLee; Greg Harris; Nico Van Rooijen; Girishchandra B Patel; Wangxue Chen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more
  17 in total

1.  NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection.

Authors:  N Dikshit; S D Kale; H J Khameneh; V Balamuralidhar; C Y Tang; P Kumar; T P Lim; T T Tan; A L Kwa; A Mortellaro; B Sukumaran
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice.

Authors:  Min-Jung Kang; Sung-Gang Jo; Dong-Jae Kim; Jong-Hwan Park
Journal:  Immunology       Date:  2017-01-30       Impact factor: 7.397

4.  RAGE-Mediated Suppression of Interleukin-10 Results in Enhanced Mortality in a Murine Model of Acinetobacter baumannii Sepsis.

Authors:  Michael J Noto; Kyle W Becker; Kelli L Boyd; Ann Marie Schmidt; Eric P Skaar
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 5.  Innate Immune Responses to Acinetobacter baumannii in the Airway.

Authors:  Sílvia Pires; Dane Parker
Journal:  J Interferon Cytokine Res       Date:  2019-04-23       Impact factor: 2.607

Review 6.  Uncovering the mechanisms of Acinetobacter baumannii virulence.

Authors:  Christian M Harding; Seth W Hennon; Mario F Feldman
Journal:  Nat Rev Microbiol       Date:  2017-12-18       Impact factor: 60.633

7.  Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs.

Authors:  Sandeep D Kale; Neha Dikshit; Pankaj Kumar; Vanniarajan Balamuralidhar; Hanif Javanmard Khameneh; Najib Bin Abdul Malik; Tse Hsien Koh; Gladys Gek Yen Tan; Thuan Tong Tan; Alessandra Mortellaro; Bindu Sukumaran
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

8.  CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies.

Authors:  Te Ha Kim; Dongbum Kim; Avishekh Gautam; Heesu Lee; Min Hyung Kwak; Min Chul Park; Sangkyu Park; Guang Wu; Bok Luel Lee; Younghee Lee; Hyung-Joo Kwon
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

9.  Carbapenem-Resistant Acinetobacter baumannii in Three Tertiary Care Hospitals in Mexico: Virulence Profiles, Innate Immune Response and Clonal Dissemination.

Authors:  María Dolores Alcántar-Curiel; Roberto Rosales-Reyes; Ma Dolores Jarillo-Quijada; Catalina Gayosso-Vázquez; José Luis Fernández-Vázquez; José Eduardo Toledano-Tableros; Silvia Giono-Cerezo; Paola Garza-Villafuerte; Arath López-Huerta; Daniela Vences-Vences; Rayo Morfín-Otero; Eduardo Rodríguez-Noriega; María Del Rocío López-Álvarez; María Del Carmen Espinosa-Sotero; José Ignacio Santos-Preciado
Journal:  Front Microbiol       Date:  2019-09-20       Impact factor: 5.640

10.  Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence.

Authors:  Christian M Harding; Rachel L Kinsella; Lauren D Palmer; Eric P Skaar; Mario F Feldman
Journal:  PLoS Pathog       Date:  2016-01-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.